The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference (Englisch)
- Neue Suche nach: Hatzakis, A.
- Neue Suche nach: Van Damme, P.
- Neue Suche nach: Alcorn, K.
- Neue Suche nach: Gore, C.
- Neue Suche nach: Benazzouz, M.
- Neue Suche nach: Berkane, S.
- Neue Suche nach: Buti, M.
- Neue Suche nach: Carballo, M.
- Neue Suche nach: Cortes Martins, H.
- Neue Suche nach: Deuffic‐Burban, S.
- Neue Suche nach: Dominguez, A.
- Neue Suche nach: Donoghoe, M.
- Neue Suche nach: Elzouki, A‐N.
- Neue Suche nach: Ben‐Alaya Bouafif, N.
- Neue Suche nach: Esmat, G.
- Neue Suche nach: Esteban, R.
- Neue Suche nach: Fabri, M.
- Neue Suche nach: Fenton, K.
- Neue Suche nach: Goldberg, D.
- Neue Suche nach: Goulis, I.
- Neue Suche nach: Hadjichristodoulou, T.
- Neue Suche nach: Hatzigeorgiou, T.
- Neue Suche nach: Hamouda, O.
- Neue Suche nach: Hasurdjiev, S.
- Neue Suche nach: Hughes, S.
- Neue Suche nach: Kautz, A.
- Neue Suche nach: Malik, M.
- Neue Suche nach: Manolakopoulos, S.
- Neue Suche nach: Matičič, M.
- Neue Suche nach: Papatheodoridis, G.
- Neue Suche nach: Peck, R.
- Neue Suche nach: Peterle, A.
- Neue Suche nach: Potamitis, G.
- Neue Suche nach: Prati, D.
- Neue Suche nach: Roudot‐Thoraval, F.
- Neue Suche nach: Reic, T.
- Neue Suche nach: Sharara, A.
- Neue Suche nach: Shennak, M.
- Neue Suche nach: Shiha, G.
- Neue Suche nach: Shouval, D.
- Neue Suche nach: Sočan, M.
- Neue Suche nach: Thomas, H.
- Neue Suche nach: Thursz, M.
- Neue Suche nach: Tosti, M.
- Neue Suche nach: Trépo, C.
- Neue Suche nach: Vince, A.
- Neue Suche nach: Vounou, E.
- Neue Suche nach: Wiessing, L.
- Neue Suche nach: Manns, M.
- Neue Suche nach: Hatzakis, A.
- Neue Suche nach: Van Damme, P.
- Neue Suche nach: Alcorn, K.
- Neue Suche nach: Gore, C.
- Neue Suche nach: Benazzouz, M.
- Neue Suche nach: Berkane, S.
- Neue Suche nach: Buti, M.
- Neue Suche nach: Carballo, M.
- Neue Suche nach: Cortes Martins, H.
- Neue Suche nach: Deuffic‐Burban, S.
- Neue Suche nach: Dominguez, A.
- Neue Suche nach: Donoghoe, M.
- Neue Suche nach: Elzouki, A‐N.
- Neue Suche nach: Ben‐Alaya Bouafif, N.
- Neue Suche nach: Esmat, G.
- Neue Suche nach: Esteban, R.
- Neue Suche nach: Fabri, M.
- Neue Suche nach: Fenton, K.
- Neue Suche nach: Goldberg, D.
- Neue Suche nach: Goulis, I.
- Neue Suche nach: Hadjichristodoulou, T.
- Neue Suche nach: Hatzigeorgiou, T.
- Neue Suche nach: Hamouda, O.
- Neue Suche nach: Hasurdjiev, S.
- Neue Suche nach: Hughes, S.
- Neue Suche nach: Kautz, A.
- Neue Suche nach: Malik, M.
- Neue Suche nach: Manolakopoulos, S.
- Neue Suche nach: Matičič, M.
- Neue Suche nach: Papatheodoridis, G.
- Neue Suche nach: Peck, R.
- Neue Suche nach: Peterle, A.
- Neue Suche nach: Potamitis, G.
- Neue Suche nach: Prati, D.
- Neue Suche nach: Roudot‐Thoraval, F.
- Neue Suche nach: Reic, T.
- Neue Suche nach: Sharara, A.
- Neue Suche nach: Shennak, M.
- Neue Suche nach: Shiha, G.
- Neue Suche nach: Shouval, D.
- Neue Suche nach: Sočan, M.
- Neue Suche nach: Thomas, H.
- Neue Suche nach: Thursz, M.
- Neue Suche nach: Tosti, M.
- Neue Suche nach: Trépo, C.
- Neue Suche nach: Vince, A.
- Neue Suche nach: Vounou, E.
- Neue Suche nach: Wiessing, L.
- Neue Suche nach: Manns, M.
In:
Journal of Viral Hepatitis
;
20
;
1-20
;
2013
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference
-
Beteiligte:Hatzakis, A. ( Autor:in ) / Van Damme, P. ( Autor:in ) / Alcorn, K. ( Autor:in ) / Gore, C. ( Autor:in ) / Benazzouz, M. ( Autor:in ) / Berkane, S. ( Autor:in ) / Buti, M. ( Autor:in ) / Carballo, M. ( Autor:in ) / Cortes Martins, H. ( Autor:in ) / Deuffic‐Burban, S. ( Autor:in )
-
Erschienen in:Journal of Viral Hepatitis ; 20 ; 1-20
-
Verlag:
-
Erscheinungsdatum:01.08.2013
-
Format / Umfang:20 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 20
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit ConferenceHatzakis, A. / Van Damme, P. / Alcorn, K. / Gore, C. / Benazzouz, M. / Berkane, S. / Buti, M. / Carballo, M. / Cortes Martins, H. / Deuffic‐Burban, S. et al. | 2013
- 1
-
A different look at the management of chronic hepatitis B in a resource‐constrained countryJia, J. et al. | 2013
- 1
-
Hepatitis E: source and route of infection, clinical manifestations and new developmentsScobie, L. / Dalton, H. R. et al. | 2013
- 1
-
Keynote Lectures| 2013
- 2
-
Treatment of chronic Hepatitis B in resource‐constrained countries: an economic solution is requiredThomas, Howard et al. | 2013
- 2
-
Oral Papers| 2013
- 3
-
Telbivudine treatment in chronic hepatitis B: experience from ChinaYou, H. / Jia, J. et al. | 2013
- 9
-
Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patientsWang, G.‐Q. / Ding, Y.‐P. / Dong, Y.‐H. et al. | 2013
- 12
-
A systematic analysis of the predicted human La protein targets identified a hepatitis B virus infection signatureTang, J. / Zhang, Z.‐H. / Liu, G.‐L. et al. | 2013
- 16
-
Poster Sessions| 2013
- 18
-
Rapid downregulation of programmed death‐1 and interferon‐γ‐inducible protein‐10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis BHou, F.‐Q. / Wu, X.‐J. / Wang, Y. / Chen, J. / Liu, Y.‐Z. / Ren, Y.‐Y. / Song, G. / Ding, Y.‐P. / Yu, M. / Wang, G.‐Q. et al. | 2013
- 24
-
Phosphorylation of human La protein at Ser366 by casein kinase II contributes to hepatitis B virus replication and expression in vitroTang, J. / Zhang, Z.‐H. / Huang, M. / Heise, T. / Zhang, J. / Liu, G.‐L. et al. | 2013
- 27
-
PD‐1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replicationWang, X. F. / Lei, Y. / Chen, M. / Chen, C. B. / Ren, H. / Shi, T. D. et al. | 2013
- 34
-
The metabolic regulator PGC‐1α links anti‐cancer cytotoxic chemotherapy to reactivation of hepatitis B virusMouler Rechtman, M. / Burdelova, E. O. / Bar‐Yishay, I. / Ben‐Yehoyada, M. / Fishman, S. / Halpern, Z. / Shlomai, A. et al. | 2013
- 40
-
Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg‐positive chronic hepatitis B patients with resistance to adefovir dipivoxilLu, Jia‐Jie / Liu, Kai / Ma, Yuan‐Ji / Wang, Juan / Chen, En‐Qiang / Tang, Hong et al. | 2013
- 42
-
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV‐infected individuals with occult HBV infectionCassini, R. / De Mitri, M. S. / Gibellini, D. / Urbinati, L. / Bagaglio, S. / Morsica, G. / Domenicali, M. / Verucchi, G. / Bernardi, M. et al. | 2013
- 43
-
Author Index| 2013
- 46
-
Efficacy of telbivudine treatment for hepatitis B e antigen‐positive chronic hepatitis B patients with poor response to adefovir dipivoxilLi, Y. / Zhang, Y. / Wang, J.‐P. / Lian, J.‐Q. / Bai, X.‐F. et al. | 2013
- 50
-
Hepatitis B virus X gene differentially modulates cell cycle progression and apoptotic protein expression in hepatocyte versus hepatoma cell linesYang, C. H. / Cho, M. et al. | 2013
- 52
-
Efficacy of sequential use of telbivudine in hepatitis B e antigen‐positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot studyHuang, Z. / Zhao, Z. / Zheng, Y. / Peng, L. / Lin, C. / Deng, H. / Gao, Z. et al. | 2013
- 58
-
Forty‐eight‐week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B‐related cirrhosisHan, Z. / Shi, Y. / Zhu, J. / Chen, Y. / Yin, F. / Xia, L. / Luo, G. / Gao, Z. / Liu, J. / Jia, G. et al. | 2013
- 59
-
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4Antaki, N. / Bibert, S. / Kebbewar, K. / Asaad, F. / Baroudi, O. / Alideeb, S. / Hadad, M. / Abboud, D. / Sabah, H. / Bochud, P.‐Y. et al. | 2013
- 65
-
Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancyLiu, M. / Cai, H. / Yi, W. et al. | 2013
- 65
-
Therapy‐induced clearance of HCV core antigen from plasma predicts an end of treatment viral responseTedder, R. S. / Tuke, P. / Wallis, N. / Wright, M. / Nicholson, L. / Grant, P. R. et al. | 2013
- 72
-
Noninvasive estimation of fibrosis progression overtime using the FIB‐4 index in chronic hepatitis CTamaki, N. / Kurosaki, M. / Tanaka, K. / Suzuki, Y. / Hoshioka, Y. / Kato, T. / Yasui, Y. / Hosokawa, T. / Ueda, K. / Tsuchiya, K. et al. | 2013
- 77
-
Hepatitis C virus diversity and hepatic steatosisRoingeard, P. et al. | 2013
- 85
-
Persistent hepatitis C virus (HCV) infection impairs HCV‐specific cytotoxic T cell reactivity through Mcl‐1/Bim imbalance due to CD127 down‐regulationLarrubia, J. R. / Lokhande, M. U. / García‐Garzón, S. / Miquel, J. / González‐Praetorius, A. / Parra‐Cid, T. / Sanz‐de‐Villalobos, E. et al. | 2013
- 95
-
Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis CShlomai, A. / Halfon, P. / Goldiner, I. / Zelber‐Sagi, S. / Halpern, Z. / Oren, R. / Bruck, R. et al. | 2013
- 103
-
RNA aptamer‐mediated interference of HCV replication by targeting the CRE‐5BSL3.2 domainMarton, S. / Romero‐López, C. / Berzal‐Herranz, A. et al. | 2013
- 113
-
Role of IL‐28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg‐Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varicesDi Marco, V. / Calvaruso, V. / Grimaudo, S. / Ferraro, D. / Pipitone, R. M. / Di Stefano, R. / Craxì, A. et al. | 2013
- 122
-
Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individualsKowalec, K. / Minuk, G. Y. / Børresen, M. L. / Koch, A. / McMahon, B. J. / Simons, B. / Osiowy, C. et al. | 2013
- 131
-
Hepatitis B virus wild‐type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir‐based regimenSvarovskaia, E. S. / Curtis, M. / Zhu, Y. / Borroto‐Esoda, K. / Miller, M. D. / Berg, T. / Lavocat, F. / Zoulim, F. / Kitrinos, K. M. et al. | 2013
- 141
-
Hepatitis B e antigen‐suppressing mutations enhance the replication efficiency of adefovir‐resistant hepatitis B virus strainsHerbers, U. / Amini‐Bavil‐Olyaee, S. / Mueller, A. / Luedde, T. / Trautwein, C. / Tacke, F. et al. | 2013
- 149
-
Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an updateKew, M. C. et al. | 2013
- 158
-
Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte‐derived microRNA‐122van der Meer, A. J. / Farid, W. R. R. / Sonneveld, M. J. / de Ruiter, P. E. / Boonstra, A. / van Vuuren, A. J. / Verheij, J. / Hansen, B. E. / de Knegt, R. J. / van der Laan, L. J. W. et al. | 2013
- 167
-
Virological response and safety of 24‐week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1bToyota, J. / Ozeki, I. / Karino, Y. / Asahina, Y. / Izumi, N. / Takahashi, S. / Kawakami, Y. / Chayama, K. / Kamiya, N. / Aoki, K. et al. | 2013
- 174
-
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis CPetta, S. / Handberg, A. / Marchesini, G. / Cammà, C. / Di Marco, V. / Cabibi, D. / Macaluso, F. S. / Craxì, A. et al. | 2013
- 183
-
In situ hybridization for the detection of hepatitis C virus RNA in human liver tissueLi, G. / Li, K. / Lea, A. S. / Li, N. L. / Abdulla, N. E. / Eltorky, M. A. / Ferguson, M. R. et al. | 2013
- 193
-
HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphismStenkvist, J. / Sönnerborg, A. / Weiland, O. et al. | 2013
- 200
-
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infectionMorisco, F. / Castiglione, F. / Rispo, A. / Stroffolini, T. / Sansone, S. / Vitale, R. / Guarino, M. / Biancone, L. / Caruso, A. / D'Inca, R. et al. | 2013
- 209
-
New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg‐negative infection in Eastern IndiaGhosh, S. / Banerjee, P. / Deny, P. / Mondal, R. K. / Nandi, M. / RoyChoudhury, A. / Das, K. / Banerjee, S. / Santra, A. / Zoulim, F. et al. | 2013
- 219
-
Synergistic Effects of A1896, T1653 and T1762/A1764 Mutations in Genotype C2 Hepatitis B Virus on Development of Hepatocellular CarcinomaLyu, H. / Lee, D. / Chung, Y.‐H. / Kim, J. A. / Lee, J.‐H. / Jin, Y.‐J. / Park, W. / Mathews, P. / Jaffee, E. / Zheng, L. et al. | 2013
- 225
-
Are trans‐complementation systems suitable for hepatitis C virus life cycle studies?Fournier, C. / Duverlie, G. / Castelain, S. et al. | 2013
- 234
-
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low‐to‐moderate genetic barrier nucleoside analogsPeveling‐Oberhag, J. / Herrmann, E. / Kronenberger, B. / Farnik, H. / Susser, S. / Sarrazin, C. / Zeuzem, S. / Hofmann, W.‐P. et al. | 2013
- 240
-
Acoustic radiation force impulse imaging for non‐invasive assessment of liver fibrosis in chronic hepatitis BFriedrich‐Rust, M. / Buggisch, P. / de Knegt, R. J. / Dries, V. / Shi, Y. / Matschenz, K. / Schneider, M. D. / Herrmann, E. / Petersen, J. / Schulze, F. et al. | 2013
- 248
-
A model to predict 3‐month mortality risk of acute‐on‐chronic hepatitis B liver failure using artificial neural networkZheng, M.‐H. / Shi, K.‐Q. / Lin, X.‐F. / Xiao, D.‐D. / Chen, L.‐L. / Liu, W.‐Y. / Fan, Y.‐C. / Chen, Y.‐P. et al. | 2013
- 256
-
Development and assessment of a novel real‐time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis DKatsoulidou, A. / Manesis, E. / Rokka, C. / Issaris, C. / Pagoni, A. / Sypsa, V. / Hatzakis, A. et al. | 2013
- 263
-
Genetic variations in host IL28B links to the detection of peripheral blood mononuclear cells–associated hepatitis C virus RNA in chronically infected patientsAngulo, J. / Pino, K. / Pavez, C. / Biel, F. / Labbé, P. / Miquel, J. F. / Soza, A. / López‐Lastra, M. et al. | 2013
- 273
-
Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis CZheng, Y.‐Y. / Wang, L.‐F. / Fan, X.‐H. / Wu, C.‐H. / Huo, N. / Lu, H.‐Y. / Xu, X.‐Y. / Wei, L. et al. | 2013
- 281
-
IL‐28B (IFN‐λ3) and IFN‐α synergistically inhibit HCV replicationShindo, H. / Maekawa, S. / Komase, K. / Miura, M. / Kadokura, M. / Sueki, R. / Komatsu, N. / Shindo, K. / Amemiya, F. / Nakayama, Y. et al. | 2013
- 290
-
Rapid immunoassay alone is insufficient for the detection of hepatitis C virus infection among high‐risk populationFirdaus, R. / Saha, K. / Sadhukhan, P. C. et al. | 2013
- 294
-
Towards realistic estimates of HCV incidence in EgyptBreban, R. / Doss, W. / Esmat, G. / Elsayed, M. / Hellard, M. / Ayscue, P. / Albert, M. / Fontanet, A. / Mohamed, M. K. et al. | 2013
- 297
-
The role of the hepatitis viruses in cholangiocarcinomaRalphs, S. / Khan, S. A. et al. | 2013
- 306
-
Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumoursWu, Z.‐F. / Yang, N. / Li, D.‐Y. / Zhang, H.‐B. / Yang, G.‐S. et al. | 2013
- 311
-
Cure for immune‐tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon?Poddar, U. / Yachha, S. K. / Agarwal, J. / Krishnani, N. et al. | 2013
- 317
-
Risk factors of HBV intrauterine transmission among HBsAg‐positive pregnant womenGuo, Z. / Shi, X. H. / Feng, Y. L. / Wang, B. / Feng, L .P. / Wang, S. P. / Zhang, Y. W. et al. | 2013
- 322
-
Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analoguesZoutendijk, R. / Sonneveld, M. J. / Reijnders, J. G. P. / van Vuuren, A. J. / Biesta, P. / Hansen, B. E. / Boonstra, A. / Janssen, H. L. A. et al. | 2013
- 328
-
Histological improvement of long‐term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levelsDu, X. / Wang, J. / Shao, L. / Hu, X. / Yang, C. / Shen, L. / Weng, X. / Zhang, W. et al. | 2013
- 336
-
Antiviral therapy decreases viral reactivation in patients with hepatitis B virus–related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trialHuang, L. / Li, J. / Yan, J. / Sun, J. / Zhang, X. / Wu, M. / Yan, Y. et al. | 2013
- 343
-
Maternal hepatitis B surface antigen status and incidence of pre‐eclampsiaLao, T. T. / Sahota, D. S. / Cheng, Y. K. Y. / Law, L. W. / Leung, T. Y. et al. | 2013
- 350
-
Hepatocyte destruction with enhanced collagen synthesis: characteristic feature of chronic hepatitis C patients on haemodialysisUe, M. / Ikebe, N. / Munekage, K. / Ochi, T. / Hirose, A. / Kataoka, H. / Fujimoto, S. / Kikuchi, K. / Okuhara, Y. / Ono, M. et al. | 2013
- 358
-
IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus‐/HCV‐coinfected patientsJiménez‐Sousa, M. A. / Berenguer, J. / Rallón, N. / Guzmán‐Fulgencio, M. / López, J. C. / Soriano, V. / Fernández‐Rodríguez, A. / Cosín, J. / Restrepo, C. / García‐Álvarez, M. et al. | 2013
- 367
-
What about us? Recent advances in the treatment of chronic hepatitis C threaten to leave some parts of the world behindAhmed, F. et al. | 2013
- 369
-
Virus‐neutralizing antibodies to hepatitis C virusWahid, A. / Dubuisson, J. et al. | 2013
- 377
-
IL‐28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta‐analysisRangnekar, A. S. / Fontana, R. J. et al. | 2013
- 385
-
Induction of interferon‐λ contributes to Toll‐like receptor‐3‐activated hepatic stellate cell–mediated hepatitis C virus inhibition in hepatocytesWang, Y. / Li, J. / Wang, X. / Ye, L. / Zhou, Y. / Ho, W. et al. | 2013
- 395
-
Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypesDe Meyer, S. / Ghys, A. / Foster, G. R. / Beumont, M. / Van Baelen, B. / Lin, T.‐I. / Dierynck, I. / Ceulemans, H. / Picchio, G. et al. | 2013
- 404
-
Anti‐inflammatory cytokines, pro‐fibrogenic chemokines and persistence of acute HCV infectionOsburn, W. O. / Levine, J. S. / Chattergoon, M. A. / Thomas, D. L. / Cox, A. L. et al. | 2013
- 414
-
The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from the Los Alamos databankAlves, R. / Queiroz, A. T. L. / Pessoa, M. G. / da Silva, E. F. / Mazo, D. F. C. / Carrilho, F. J. / Carvalho‐Filho, R. J. / de Carvalho, I. M. V. G. et al. | 2013
- 422
-
Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and Architect assaysZhou, B. / Liu, M. / Lv, G. / Zheng, H. / Wang, Y. / Sun, J. / Hou, J. et al. | 2013
- 430
-
DNA methylation patterns of peroxisome proliferator‐activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis BZhao, Q. / Fan, Y. ‐C. / Zhao, J. / Gao, S. / Zhao, Z. ‐H. / Wang, K. et al. | 2013
- 438
-
Identification of HEV in symptom‐free migrants and environmental samples in ItalyIdolo, A. / Serio, F. / Lugoli, F. / Grassi, T. / Bagordo, F. / Guido, M. / Privitera, G. / Lobreglio, G. / De Donno, A. et al. | 2013
- 444
-
Maternal HBsAg status and infant size: the importance of viral load and HBsAg quantificationElefsiniotis, I. S. / Magaziotou, I. / Brokalaki, H. / Tsoumakas, K. et al. | 2013
- 445
-
Anti‐HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic reviewChen, Y. / Zhu, J. et al. | 2013
- 453
-
Impact of oral silymarin on virus‐ and non‐virus‐specific T‐cell responses in chronic hepatitis C infectionAdeyemo, O. / Doi, H. / Rajender Reddy, K. / Kaplan, D. E. / SyNCH Trial Investigators et al. | 2013
- 463
-
Hepatitis C virus treatment and survival in patients with hepatitis C and human immunodeficiency virus co‐infection and baseline anaemiaErqou, S. / Mohanty, A. / McGinnis, K. A. / Vanasse, G. / Freiberg, M. S. / Sherman, K. E. / Butt, A. A. et al. | 2013
- 470
-
Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infectionSeto, W.‐K. / Tsang, O. T.‐Y. / Liu, K. / Chan, J. M.‐C. / Wong, D. K.‐H. / Fung, J. / Lai, C.‐L. / Yuen, M.‐F. et al. | 2013
- 478
-
Thermostability of seven hepatitis C virus genotypes in vitro and in vivoDoerrbecker, J. / Meuleman, P. / Kang, J. / Riebesehl, N. / Wilhelm, C. / Friesland, M. / Pfaender, S. / Steinmann, J. / Pietschmann, T. / Steinmann, E. et al. | 2013
- 486
-
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patientsPetta, S. / Grimaudo, S. / Marco, V. D. / Scazzone, C. / Macaluso, F. S. / Cammà, C. / Cabibi, D. / Pipitone, R. / Craxì, A. et al. | 2013
- 494
-
Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide studyKhedive, A. / Norouzi, M. / Ramezani, F. / Karimzadeh, H. / Alavian, S. M. / Malekzadeh, R. / Montazeri, G. / Nejatizadeh, A. / Ziaee, M. / Abedi, F. et al. | 2013
- 502
-
Long‐term outcome of hepatitis B virus‐related Chronic Hepatitis under protracted nucleos(t)ide analoguesNiro, G. A. / Ippolito, A. M. / Fontana, R. / Valvano, M. R. / Gioffreda, D. / Iacobellis, A. / Merla, A. / Durazzo, M. / Lotti, G. / Di Mauro, L. et al. | 2013
- 510
-
Incidence of diabetes mellitus in a population‐based cohort of persons with chronic hepatitis B virus infectionSpradling, P. R. / Simons, B. / Narayanan, M. / Xing, J. / Homan, C. / Bulkow, L. / Cagle, H. / Schraer, C. D. / McMahon, B. J. et al. | 2013
- 514
-
Hepatocellular carcinoma screening among hepatitis B‐infected Asian AmericansBraillon, A. et al. | 2013
- 515
-
Hepatocellular screening in hepatitis‐B infected Asian AmericansKhalili, M. / Stewart, S. et al. | 2013
- 517
-
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis CZampino, R. / Coppola, N. / Cirillo, G. / Boemio, A. / Pisaturo, M. / Marrone, A. / Macera, M. / Sagnelli, E. / Perrone, L. / Adinolfi, L. E. et al. | 2013
- 524
-
Long‐term clearance of hepatitis C virus following interferon α‐2b or peginterferon α‐2b, alone or in combination with ribavirinManns, M. P. / Pockros, P. J. / Norkrans, G. / Smith, C. I. / Morgan, T. R. / Häussinger, D. / Shiffman, M. L. / Hadziyannis, S. J. / Schmidt, W. N. / Jacobson, I. M. et al. | 2013
- 530
-
Serum microRNA‐122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapyKöberle, V. / Waidmann, O. / Kronenberger, B. / Andrei, A. / Susser, S. / Füller, C. / Perner, D. / Zeuzem, S. / Sarrazin, C. / Piiper, A. et al. | 2013
- 536
-
Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistenceEvon, D. M. / Esserman, D. A. / Bonner, J. E. / Rao, T. / Fried, M. W. / Golin, C. E. et al. | 2013
- 550
-
Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis CYounossi, Z. M. / Stepanova, M. / Afendy, M. / Lam, B. P. / Mishra, A. et al. | 2013
- 556
-
Ex vivo analysis of resident hepatic pro‐inflammatory CD1d‐reactive T cells and hepatocyte surface CD1d expression in hepatitis CYanagisawa, K. / Yue, S. / van der Vliet, H. J. / Wang, R. / Alatrakchi, N. / Golden‐Mason, L. / Schuppan, D. / Koziel, M. J. / Rosen, H. R. / Exley, M. A. et al. | 2013
- 566
-
Complementary laboratory indices for predicting the disease status of patients with hepatitis B virus infectionChen, F. / He, J. L. / Zheng, M. / Zhu, H. H. / Li, S. P. / Wang, K. / Zhang, X. X. / Zhao, Y. R. / Wu, S. S. / Chen, Z. et al. | 2013
- 575
-
Demographic and serological characteristics of Asian Americans with hepatitis B infection diagnosed at community screeningsXu, J. J. / Tien, C. / Chang, M. / Rhee, J. / Tien, A. / Bae, H. S. / Ho, F. C.‐S. / Chan, L. S. / Fong, T.‐L. et al. | 2013
- 582
-
Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in Hepatitis B virus‐positive newbornsShrivastava, S. / TrehanPati, N. / Patra, S. / Kottilil, S. / Pande, C. / Trivedi, S. S. / Sarin, S. K. et al. | 2013
- 592
-
Evidence that pulmonary vascular pathology explains the decline in lung function associated with interferon α based therapies for chronic hepatitis C virusGeorge, Peter M. / Mitchell, Jane A. et al. | 2013
- 593
-
Interferon‐associated retinopathy during the treatment of chronic hepatitis C: a systematic reviewRaza, A. / Mittal, S. / Sood, G. K. et al. | 2013
- 600
-
Viral hepatitis and the Global Burden of Disease: a need to regroupCooke, G. S. / Lemoine, M. / Thursz, M. / Gore, C. / Swan, T. / Kamarulzaman, A. / DuCros, P. / Ford, N. et al. | 2013
- 602
-
Relationship between IL‐10 gene −1082A/G and −592C/A polymorphisms and the risk of hepatitis C infection: a meta‐analysisSun, X.‐R. / Wu, J. / Shi, K.‐Q. / Tang, K.‐F. et al. | 2013
- 612
-
Protein phosphatase 2A impairs IFNα‐induced antiviral activity against the hepatitis C virus through the inhibition of STAT1 tyrosine phosphorylationShanker, V. / Trincucci, G. / Heim, H. M. / Duong, H. T. F. et al. | 2013
- 622
-
A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patientsBader, T. / Hughes, L. D. / Fazili, J. / Frost, B. / Dunnam, M. / Gonterman, A. / Madhoun, M. / Aston, C. E. et al. | 2013
- 628
-
Hospitalizations due to hepatitis C in Los Angeles County, 2007–2009: case characteristics and factors associated with mortalitySie, L. / Gatto, N. M. / Bancroft, E. et al. | 2013
- 638
-
Targeted case finding for hepatitis B using dry blood spot testing in the British–Chinese and South Asian populations of the North‐East of EnglandMcPherson, S. / Valappil, M. / Moses, S. E. / Eltringham, G. / Miller, C. / Baxter, K. / Chan, A. / Shafiq, K. / Saeed, A. / Qureshi, R. et al. | 2013
- 645
-
The effects of nucleoside analogue prophylactic treatment on HBV activation in HBcAb+ patients undergoing immunosuppressive therapyLiu, H.‐L. / Zhao, Z. / Yang, H. / Liu, F.‐F. / Liu, Q. / Luo, Q. / Yuan, Q. / Chen, L.‐M. / Zeng, A.‐Z. et al. | 2013
- 650
-
Evolution of glomerular filtration rate in HIV‐infected, HIV–HBV‐coinfected and HBV‐infected patients receiving tenofovir disoproxil fumaratePradat, P. / Le Pogam, M.‐A. / Okon, J.‐B. / Trolliet, P. / Miailhes, P. / Brochier, C. / Maynard, M. / Bailly, F. / Zoulim, F. / Cotte, L. et al. | 2013
- 658
-
Reduced ADP‐ribosylation by PARP1 natural polymorphism V762A and by PARP1 inhibitors enhance Hepatitis B virus replicationKo, H. L. / Ng, H. J. / Goh, E. H. / Ren, E. C. et al. | 2013
- 666
-
Quantifying current hepatitis C virus incidence in EgyptMiller, F. D. / Abu‐Raddad, L. J. et al. | 2013
- 668
-
Quantifying current hepatitis C virus incidence in Egypt – Response to letter by Miller and Abu‐RaddadBreban, R. / Doss, W. / Esmat, G. / Elsayed, M. / Hellard, M. / Ayscue, P. / Albert, M. / Fontanet, A. / Mohamed, M. K. et al. | 2013
- 669
-
Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3Tapper, E. B. / Afdhal, N. H. et al. | 2013
- 678
-
Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan populationEzzikouri, S. / Kitab, B. / Rebbani, K. / Marchio, A. / Wain‐Hobson, S. / Dejean, A. / Vartanian, J.‐P. / Pineau, P. / Benjelloun, S. et al. | 2013
- 687
-
Hepatitis B virus‐induced hepatocellular carcinoma: functional roles of MICA variantsTong, H. V. / Toan, N. L. / Song, L. H. / Bock, C.‐T. / Kremsner, P. G. / Velavan, T. P. et al. | 2013
- 699
-
All‐oral therapy with nucleotide inhibitors sofosbuvir and GS‐0938 for 14 days in treatment‐naive genotype 1 hepatitis C (NUCLEAR)Lawitz, E. J. / Rodriguez‐Torres, M. / Denning, J. / Mathias, A. / Mo, H. / Gao, B. / Cornpropst, M. T. / Berrey, M. M. / Symonds, W. T. et al. | 2013
- 708
-
Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono‐infected and HCV/HIV co‐infected adultsChen, E. Y. / North, C. S. / Fatunde, O. / Bernstein, I. / Salari, S. / Day, B. / Jain, M. K. et al. | 2013
- 715
-
Effect of hepatitis C virus on immunological and virological responses in HIV‐infected patients initiating highly active antiretroviral therapy: a meta‐analysisTsiara, C. G. / Nikolopoulos, G. K. / Dimou, N. L. / Bagos, P. G. / Saroglou, G. / Velonakis, E. / Hatzakis, A. et al. | 2013
- 725
-
Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two‐centre, masked, case–control studySugden, P. B. / Pham, T. N. Q. / Ratnarajah, S. / Cameron, B. / Bull, R. / White, P. A. / Michalak, T. I. / Lloyd, A. R. / the HITS investigators et al. | 2013
- 729
-
A systematic review and meta‐analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis‐related hepatocellular carcinomaHuang, T.‐S. / Shyu, Y.‐C. / Chen, H.‐Y. / Yuan, S.‐S. / Shih, J.‐N. / Chen, P.‐J. et al. | 2013
- 744
-
Erratum| 2013
- 745
-
The new paradigm of hepatitis C therapy: integration of oral therapies into best practicesAfdhal, N. H. / Zeuzem, S. / Schooley, R. T. / Thomas, D. L. / Ward, J. W. / Litwin, A. H. / Razavi, H. / Castera, L. / Poynard, T. / Muir, A. et al. | 2013
- 761
-
Role of hepatitis C virus substitutions and interleukin‐28B polymorphism on response to peginterferon plus ribavirin in a prospective study of response‐guided therapyLiang, C.‐M. / Hu, T.‐H. / Lu, S.‐N. / Hung, C.‐H. / Huang, C.‐M. / Wang, J.‐H. / Yen, Y.‐H. / Chen, C.‐H. / Chang, K.‐C. / Tsai, M.‐C. et al. | 2013
- 770
-
Evolution of fibrosis during HCV recurrence after liver transplantation – influence of IL‐28B SNP and response to peg‐IFN and ribavirin treatmentAckefors, M. / Nyström, J. / Wernerson, A. / Gjertsen, H. / Sönnerborg, A. / Weiland, O. et al. | 2013
- 779
-
Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitorde Bruijne, J. / Thomas, X. V. / Rebers, S. P. / Weegink, C. J. / Treitel, M. A. / Hughes, E. / Bergmann, J. F. / de Knegt, R. J. / Janssen, H. L. A. / Reesink, H. W. et al. | 2013
- 790
-
Who is more likely to respond to dual treatment with pegylated‐interferon and ribavirin for chronic hepatitis C? A gender‐oriented analysisDi Marco, V. / Covolo, L. / Calvaruso, V. / Levrero, M. / Puoti, M. / Suter, F. / Gaeta, G. B. / Ferrari, C. / Raimondo, G. / Fattovich, G. et al. | 2013
- 801
-
Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg‐positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trialPande, C. / Sarin, S. K. / Patra, S. / Kumar, A. / Mishra, S. / Srivastava, S. / Bhutia, K. / Gupta, E. / Mukhopadhyay, C. K. / Dutta, A. K. et al. | 2013
- 811
-
Efficacy and safety of entecavir treatment in a heterogeneous CHB population from a ‘real‐world’ clinical practice setting in ChinaHou, J.‐L. / Jia, J.‐D. / Wei, L. / Zhao, W. / Wang, Y. M. / Cheng, M. / Tang, X. / Tan, D.‐M. / Ren, H. / Tang, H. et al. | 2013
- 821
-
The inhibition of hepatitis B virus by APOBEC cytidine deaminasesJanahi, E. M. / McGarvey, M. J. et al. | 2013
- 829
-
Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfectionCasado, J. L. / Quereda, C. / Moreno, A. / Pérez‐Elías, M. J. / Martí‐Belda, P. / Moreno, S. et al. | 2013
- 838
-
Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopeniaOgawa, E. / Furusyo, N. / Murata, M. / Ikezaki, H. / Ihara, T. / Hayashi, T. / Toyoda, K. / Okada, K. / Kainuma, M. / Kajiwara, E. et al. | 2013
- 847
-
All‐oral, interferon‐free treatment for chronic hepatitis C: cost‐effectiveness analysesHagan, L. M. / Yang, Z. / Ehteshami, M. / Schinazi, R. F. et al. | 2013
- 858
-
Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapyClark, P. J. / Aghemo, A. / Degasperi, E. / Galmozzi, E. / Urban, T. J. / Vock, D. M. / Patel, K. / Thompson, A. J. / Rumi, M. G. / D'Ambrosio, R. et al. | 2013
- 867
-
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosisCalvaruso, V. / Bronte, F. / Conte, E. / Simone, F. / Craxì, A. / Di Marco, V. et al. | 2013
- 875
-
Maternal immunization promotes the immune response of neonates towards hepatitis B vaccineZhang, W. / Guo, Z. / Zhang, L. / Liu, Z. / Li, J. / Ji, Z. / Xu, R. / Zhao, N. / Li, F. / Chen, X. et al. | 2013
- 882
-
Full genome ultra‐deep pyrosequencing associates G‐to‐A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis BBeggel, B. / Münk, C. / Däumer, M. / Hauck, K. / Häussinger, D. / Lengauer, T. / Erhardt, A. et al. | 2013
- 890
-
A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infectionMinuk, G. Y. / MacRury, S. / Uhanova, J. / Caouette, S. / Coleman, N. / Cummings, K. / Larke, B. / Vardy, L. / Triet Huyn, C. / Osiowy, C. et al. | 2013
- e1
-
PD‐1 expression on CTL may be related to more severe liver damage in CHB patients with HBV genotype C than in those with genotype B infectionXibing, G. / Xiaojuan, Y. / Juanhua, W. et al. | 2013
- e3
-
Comparison of FIB‐4 and APRI in Chinese HBV‐infected patients with persistently normal ALT and mildly elevated ALTWang, H. / Xue, L. / Yan, R. / Zhou, Y. / Wang, M. S. / Cheng, M. J. / Huang, H. J. et al. | 2013
- e11
-
Sequential therapy with entecavir and PEG‐INF in patients affected by chronic hepatitis B and high levels of HBV‐DNA with non‐D genotypesBoglione, L. / D'Avolio, A. / Cariti, G. / Milia, M. G. / Simiele, M. / De Nicolò, A. / Ghisetti, V. / Di Perri, G. et al. | 2013
- e20
-
Chronic hepatitis B virus (HBV) infection in children: 25 years' experiencePopalis, C. / Yeung, L. T. F. / Ling, S. C. / Ng, V. / Roberts, E. A. et al. | 2013
- e27
-
Mechanism of the dependence of hepatitis B virus genotype G on co‐infection with other genotypes for viral replicationSakamoto, T. / Tanaka, Y. / Watanabe, T. / Iijima, S. / Kani, S. / Sugiyama, M. / Murakami, S. / Matsuura, K. / Kusakabe, A. / Shinkai, N. et al. | 2013
- e37
-
Efficacy and safety of continuous 4‐year telbivudine treatment in patients with chronic hepatitis BWang, Y. / Thongsawat, S. / Gane, E. J. / Liaw, Y.‐F. / Jia, J. / Hou, J. / Chan, H. L. Y. / Papatheodoridis, G. / Wan, M. / Niu, J. et al. | 2013
- e47
-
Reliability, validity and sensitivity of the Chinese (simple) Short Form 36 Health Survey version 2 (SF‐36v2) in patients with chronic hepatitis BZhou, K. N. / Zhang, M. / Wu, Q. / Ji, Z. H. / Zhang, X. M. / Zhuang, G. H. et al. | 2013
- e56
-
In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genesSaade, F. / Buronfosse, T. / Guerret, S. / Pradat, P. / Chevallier, M. / Zoulim, F. / Jamard, C. / Cova, L. et al. | 2013
- e66
-
Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co‐ordinate infectious virus productionGouklani, H. / Beyer, C. / Drummer, H. / Gowans, E. J. / Netter, H. J. / Haqshenas, G. et al. | 2013
- e72
-
Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcomeMauss, S. / Berger, F. / Schober, A. / Moog, G. / Heyne, R. / John, C. / Pape, S. / Hueppe, D. / Pfeiffer‐Vornkahl, H. / Alshuth, U. et al. | 2013
- e78
-
Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long‐term follow‐upHotho, D. M. / de Bruijne, J. / Spaan, M. / Treitel, M. A. / Boonstra, A. / de Knegt, R. J. / Janssen, H. L. A. / Reesink, H. W. et al. | 2013
- e82
-
Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirinLindh, M. / Arnholm, B. / Björkman, P. / Hellstrand, K. / Lagging, M. / Nilsson, S. / Wahlberg, T. / Wallmark, E. / Weiland, O. / Wejstål, R. et al. | 2013
- e90
-
Low glomerular filtration rate is a risk factor for ribavirin‐associated anaemia in old patients with chronic hepatitis CBorroni, G. / Cazzaniga, M. / Andreoletti, M. / Ceriani, R. / Guerzoni, P. / Omazzi, B. / Pich, M. G. L. / Prada, A. / Spinzi, G. / Terreni, N. et al. | 2013
- e96
-
Correlates and characteristics of hepatitis C virus‐specific T‐cell immunity in exposed uninfected high‐risk prison inmatesCameron, B. / Galbraith, S. / Li, H. / Lloyd, A. / the HITS investigators et al. | 2013
- e107
-
Value of IL28B genotyping in patients with HCV‐related mixed cryoglobulinemia: results of a large, prospective studyPiluso, A. / Giannini, C. / Fognani, E. / Gragnani, L. / Caini, P. / Monti, M. / Petrarca, A. / Ranieri, J. / Urraro, T. / Triboli, E. et al. | 2013
- e115
-
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirinFoster, G. R. / Zeuzem, S. / Pianko, S. / Sarin, S. K. / Piratvisuth, T. / Shah, S. / Andreone, P. / Sood, A. / Chuang, W.‐L. / Lee, C.‐M. et al. | 2013
- e124
-
An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis CTakahashi, H. / Mizuta, T. / Oeda, S. / Isoda, H. / Nakashita, S. / Kawaguchi, Y. / Izumi, N. / Hirai, M. / Kurose, K. / Iwane, S. et al. | 2013
- e127
-
Dissimilar expression of multidrug resistance mdr1 and bcrp by the replication of hepatitis C virus: role of the nonstructural 5A proteinW. Rivero, C. / Rosso, N. / Gentile, E. / Cuestas, M. / Tiribelli, C. / Oubiña, J. R. / Mathet, V. L. et al. | 2013
- e131
-
Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17‐year follow‐upNunnari, G. / Pinzone, M. R. / Cacopardo, B. et al. | 2013
- e138
-
Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease‐endemic areaNaik, A. / Gupta, N. / Goel, D. / Ippagunta, S. K. / Sharma, R. K. / Aggarwal, R. et al. | 2013
- e141
-
Genetic variants of heat shock protein A1L2437 and A1B1267 as possible risk factors for hepatocellular carcinoma in IndiaMedhi, S. / Sarma, M. P. / Asim, M. / Kar, P. et al. | 2013
- e148
-
Antiviral therapy in patients with hepatitis B virus–related hepatocellular carcinoma: is it ready for universal application?Lao, X.‐M. / Xia, H. H.‐X. / Lin, X.‐J. / Li, S.‐P. et al. | 2013